Delivery Order SPE2DR25D6038-SPE2DR26F95MR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,014.02 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.57 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,275.48 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-unit dose) on May 15, 2025, with an ultimate completion date of May 16, 2025. The contract is priced on a firm fixed-price basis with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.99 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (70 individual unit doses) on December 29, 2025, with completion targeted for December 30, 2025. This competitively awarded, firm fixed price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which carries a potential value of $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $1,243.20 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on July 24, 2025, with completion targeted for July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,395.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the...
- The Defense Logistics Agency awarded a $1,882.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on November 20, 2025, with completion scheduled for November 21, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.92 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops UD 70s, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement portfolio. The place of performance is listed as Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) valued at $1,512.55. The contract, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $1,408.53 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for Refresh Plus 0.5% eye drops (30-count unit). This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by October 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp...
- SPE2DR25D6038Indefinite Delivery Contract
- SPE2DR25D6038-SPE2DR26F95MRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,166.30 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) on January 30, 2026, with an ultimate completion date of February 2, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. This contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military treatment facilities and defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/29/26 |